AR085817A1 - Derivados de isoxazolidina - Google Patents
Derivados de isoxazolidinaInfo
- Publication number
- AR085817A1 AR085817A1 ARP120100843A ARP120100843A AR085817A1 AR 085817 A1 AR085817 A1 AR 085817A1 AR P120100843 A ARP120100843 A AR P120100843A AR P120100843 A ARP120100843 A AR P120100843A AR 085817 A1 AR085817 A1 AR 085817A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- group
- branched
- linear
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0036—Nitrogen-containing hetero ring
- C07J71/0057—Nitrogen and oxygen
- C07J71/0068—Nitrogen and oxygen at position 16(17)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicinal Preparation (AREA)
Abstract
Compuestos anti-inflamatorios y anti-alérgicos de la serie de los glucocorticosteroides, métodos para preparar dichos compuestos, composiciones farmacéuticas que comprenden a los mismos y combinaciones y usos terapéuticos de los mismos.Reivindicación 1: Un compuesto caracterizado porque es de fórmula general (1) donde R1 es -(CH2)n-Z-(CH2)n’-R3 donde n y n’ son en forma independiente entre sí 0, 1 ó 2; Z es una unión simple o se selecciona entre -S-, -O- y -OC(R4R5)-; R3 se selecciona entre el grupo que consiste en: H, halógeno, CN, OH, CONH2, alquilo C1-6, alquenilo C2-4, haloalquilo C1-6, alquinilo C2-4 y alquil C1-6sulfonilo y alquil C1-6carbonilo; NR4R5, donde R4 y R5 se seleccionan en forma independiente entre el grupo que consiste en alquilo C1-6 y alcoxi C1-6; cicloalquilo C3-8, heterocicloalquilo C3-8, arilo y heteroarilo, cada uno de los cuales está opcionalmente sustituido con uno o más átomos de halógeno o grupos oxo o grupos CN; y R2 se selecciona entre el grupo que consiste en: alquilo C1-8 lineal o ramificado, alcoxi C1-6, haloalquilo C1-6, opcionalmente sustituido con uno o más grupos CN o átomos de halógeno; -(CH2)mR6, donde R6 se selecciona entre el grupo que consiste en cicloalquilo C3-8, heterocicloalquilo C3-8, arilo, arilalquilo C1-6, ariloxi, ariltio y heteroarilo, cada uno de los cuales opcionalmente sustituido con uno o más sustituyentes seleccionados entre el grupo que consiste en oxo, OH, halógeno, CN, NH2, CONH2, NO2, NHC(O)H, alquilo C1-6 lineal o ramificado, haloalquilo C1-6 lineal o ramificado, alcoxi C1-6 lineal o ramificado, haloalcoxi C1-6 lineal o ramificado, hidroxialcoxi C1-6, haloalcoxi C1-6, alcoxi C1-6carbonilo, alquil C1-6carboxilo, alquil C1-6sulfonilo y alquil C1-6sulfanilo, alquil C1-6oxisulfonilo, haloalquil C1-6sulfoniloxi, aminosulfonilo, cicloalquilo C3-8, heterocicloalquilo C3-6 y heteroarilo, donde m es 0 o un entero entre 1 y 3 y X e Y son en forma independiente H o halógeno; y sales farmacéuticamente aceptables del mismo; con la condición de que cuando R1 es un grupo -CH2OH y R2 es alquilo C1-6 o cicloalquilo C3-8, luego X e Y son átomos de flúor; o sales farmacéuticamente aceptables del mismo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11158230 | 2011-03-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR085817A1 true AR085817A1 (es) | 2013-10-30 |
Family
ID=44351355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP120100843A AR085817A1 (es) | 2011-03-15 | 2012-03-14 | Derivados de isoxazolidina |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US20120234316A1 (es) |
| EP (2) | EP2716648B1 (es) |
| JP (1) | JP6053700B2 (es) |
| KR (1) | KR101956937B1 (es) |
| CN (1) | CN103391945B (es) |
| AR (1) | AR085817A1 (es) |
| AU (1) | AU2012228334B2 (es) |
| BR (1) | BR112013023539B1 (es) |
| CA (1) | CA2850081C (es) |
| CL (1) | CL2013002629A1 (es) |
| EA (1) | EA028904B1 (es) |
| GE (1) | GEP201606566B (es) |
| IL (1) | IL228382A (es) |
| MX (1) | MX345400B (es) |
| MY (1) | MY194140A (es) |
| PE (1) | PE20140890A1 (es) |
| SG (1) | SG193262A1 (es) |
| TN (1) | TN2013000313A1 (es) |
| TW (1) | TWI658047B (es) |
| UA (1) | UA113508C2 (es) |
| WO (1) | WO2012123482A2 (es) |
| ZA (2) | ZA201306881B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112014001932A2 (pt) | 2011-08-01 | 2017-02-21 | Chiesi Farm Spa | composto, composição farmacêutica, combinação de um composto e uso de um composto |
| US9155747B2 (en) * | 2012-09-13 | 2015-10-13 | Chiesi Farmaceutici S.P.A. | Isoxazolidine derivatives |
| EP2902382A1 (en) * | 2014-01-30 | 2015-08-05 | Fundació Institut de Recerca Biomèdica IRB (Barcelona) | Primary hydroxylamines and uses thereof |
| PL3125898T3 (pl) * | 2014-03-31 | 2020-11-16 | The Scripps Research Institute | Farmakofor do indukcji trail |
| JP6559775B2 (ja) | 2014-09-03 | 2019-08-14 | ライゼン・ファーマシューティカルズ・エスアー | 二重ｐｉ３ｋデルタ‐ガンマキナーゼ阻害剤及びコルチコステロイドを含む治療方法及び組成物 |
| CN104262440B (zh) * | 2014-09-10 | 2016-08-17 | 江西赣亮医药原料有限公司 | 一种16ɑ-羟基泼尼松龙的制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL31997A (en) * | 1968-05-03 | 1974-03-14 | Lepetit Spa | Process for the preparation of pregnano(17alpha,16alpha-d)oxazolines and 16alpha,21-dihydroxy-17alpha-aminopregnanes |
| US4018774A (en) | 1976-02-13 | 1977-04-19 | E. R. Squibb & Sons, Inc. | Steroidal [16α,17-d]isoxazolidines |
| AR224124A1 (es) * | 1978-04-05 | 1981-10-30 | Syntex Inc | Procedimiento para preparar 4-halo-pregna-1,4-dieno-3,20-dionas |
| WO2005028495A1 (en) * | 2003-09-24 | 2005-03-31 | Glaxo Group Limited | Anti-inflammatory glucocorticoids |
| GB0415747D0 (en) * | 2004-07-14 | 2004-08-18 | Novartis Ag | Organic compounds |
| AU2006204052A1 (en) | 2005-01-03 | 2006-07-13 | Cytovia, Inc. | Method of treating brain cancer |
| DK2225256T3 (da) * | 2007-11-30 | 2013-03-11 | Pfizer Ltd | Nye glucocorticoidreceptoragonister |
| RU2010133722A (ru) * | 2008-02-27 | 2012-04-10 | Астразенека Аб (Se) | 16-альфа, 17-альфа-ацетальглюкокортикостероидные производные и их применение |
| CN101926805A (zh) * | 2009-06-24 | 2010-12-29 | 天津金耀集团有限公司 | 一种含有16,17异恶唑烷类甾体化合物的药物组合物 |
| AU2010294598B2 (en) * | 2009-09-11 | 2016-09-01 | Chiesi Farmaceutici S.P.A. | Pregnane derivatives condensed in the 16, 17 position with an n-substituted isoxazolidine ring as anti-inflammatory agents |
| TW201139369A (en) * | 2010-02-05 | 2011-11-16 | Chiesi Farma Spa | Pyrrolidine derivatives |
| CA2829982A1 (en) | 2011-03-15 | 2012-09-20 | Chiesi Farmaceutici S.P.A. | Isoxazolidine derivatives |
| BR112014001932A2 (pt) | 2011-08-01 | 2017-02-21 | Chiesi Farm Spa | composto, composição farmacêutica, combinação de um composto e uso de um composto |
| US9155747B2 (en) | 2012-09-13 | 2015-10-13 | Chiesi Farmaceutici S.P.A. | Isoxazolidine derivatives |
-
2012
- 2012-03-14 KR KR1020137022976A patent/KR101956937B1/ko active IP Right Grant
- 2012-03-14 EA EA201391173A patent/EA028904B1/ru not_active IP Right Cessation
- 2012-03-14 BR BR112013023539-0A patent/BR112013023539B1/pt not_active IP Right Cessation
- 2012-03-14 JP JP2013558416A patent/JP6053700B2/ja not_active Expired - Fee Related
- 2012-03-14 CN CN201280008928.3A patent/CN103391945B/zh not_active Expired - Fee Related
- 2012-03-14 GE GEAP201213223A patent/GEP201606566B/en unknown
- 2012-03-14 AU AU2012228334A patent/AU2012228334B2/en not_active Ceased
- 2012-03-14 SG SG2013065974A patent/SG193262A1/en unknown
- 2012-03-14 EP EP13197855.3A patent/EP2716648B1/en active Active
- 2012-03-14 CA CA2850081A patent/CA2850081C/en active Active
- 2012-03-14 PE PE2013002015A patent/PE20140890A1/es active IP Right Grant
- 2012-03-14 AR ARP120100843A patent/AR085817A1/es active IP Right Grant
- 2012-03-14 TW TW101108588A patent/TWI658047B/zh not_active IP Right Cessation
- 2012-03-14 MX MX2013010354A patent/MX345400B/es active IP Right Grant
- 2012-03-14 UA UAA201310933A patent/UA113508C2/uk unknown
- 2012-03-14 EP EP12711601.0A patent/EP2686332A2/en not_active Withdrawn
- 2012-03-14 MY MYPI2013002925A patent/MY194140A/en unknown
- 2012-03-14 WO PCT/EP2012/054439 patent/WO2012123482A2/en active Application Filing
- 2012-03-15 US US13/421,150 patent/US20120234316A1/en not_active Abandoned
-
2013
- 2013-07-24 TN TNP2013000313A patent/TN2013000313A1/fr unknown
- 2013-09-12 IL IL228382A patent/IL228382A/en active IP Right Grant
- 2013-09-12 ZA ZA2013/06881A patent/ZA201306881B/en unknown
- 2013-09-12 CL CL2013002629A patent/CL2013002629A1/es unknown
-
2014
- 2014-07-31 ZA ZA2014/05681A patent/ZA201405681B/en unknown
- 2014-11-10 US US14/537,184 patent/US9845337B2/en active Active
-
2017
- 2017-11-08 US US15/807,066 patent/US10280193B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR085817A1 (es) | Derivados de isoxazolidina | |
| AR114941A1 (es) | Derivados de sulfonilurea | |
| UY37513A (es) | Modulador del regulador de conductancia transmembrana de fibrosis quística, composiciones farmacéuticas, métodos de tratamiento y proceso para producir el modulador | |
| ES2722048T3 (es) | Compuestos de triazolopirimidina y usos de los mismos | |
| ES2770058T3 (es) | Compuestos y composiciones destinados a modular las actividades de quinasa de EGFR mutante | |
| SV2016005229A (es) | Inhibidores de syk | |
| AR093832A1 (es) | COMPUESTOS CON ACTIVIDAD ANTAGONISTA DE LOS RECEPTORES MUSCARINICOS Y ACTIVIDAD AGONISTA DEL RECEPTOR b2 ADRENERGICO | |
| CR20140275A (es) | Triazolopiridinas sustituidas | |
| UY33921A (es) | Oxazinopteridinas y oxazinoptiridinonas n-sustituidas | |
| UY31524A1 (es) | Nuevos compuestos 010 | |
| CR20140548A (es) | Derivados de aril-sultamo como moduladores de rorc | |
| AR052948A1 (es) | DERIVADOS DE ACETILENIL-PIRAZOLO-PIRIMIDINA COMO ANTAGONISTAS DE MGLUR2, METODOS PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y SU EMPLEO EN LA FABRICACIoN DE UN MEDICAMENTO PARA EL TRATAMIENTO DE ENFERMEDADES DEL SNC | |
| AR082699A1 (es) | Sales de fenotiazindiaminio, composicion farmaceutica en base al compuesto y proceso de preparacion del compuesto | |
| AR079689A1 (es) | Derivados de imidazo[1,2a]piridina, composiciones farmaceuticas que los comprenden y uso de los mismos en trastornos mieloproliferativos, leucemia y enfermedades inmunologicas e inflamatorias. | |
| AR088175A1 (es) | 3-pirimidin-4-il-oxazolidin-2-onas utiles para tratar cancer y composiciones farmaceuticas que las contienen | |
| AR062677A1 (es) | Derivados de biaril-sulfonamida, procesos de produccion y composiciones farmaceuticas que los comprenden | |
| AR077999A1 (es) | Antagonistas de pirimidin y triazin-hepcidina | |
| AR052568A1 (es) | Derivados de pirazolo -pirimidina como antagonstas de mglur2 | |
| AR085795A1 (es) | Compuestos de ciclohexilo tetrasustituidos utiles para tratar canceres, enfermedades autoinmunes y/o inflamatorias cronicas y composiciones farmaceuticas que los contienen | |
| AR078641A1 (es) | Amidas sustituidas con halogenoalquilo como insecticidas y acaricidas | |
| AR103742A1 (es) | Derivados de trifluorometilpropanamida | |
| AR109829A1 (es) | Derivados de piperidina puenteados | |
| ECSP066964A (es) | Nuevos beta-agonistas, procedimiento para su preparación y su uso como medicamentos | |
| ES2584556T3 (es) | Composiciones novedosas que contienen carbodiimida, un procedimiento para su preparación y su uso | |
| AR101222A1 (es) | Derivados de piridona |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |